SynthesisBMC pediatrics2025
Comparative efficacy of transdermal nitroglycerin and oral nifedipine in managing preterm labor: a systematic review and meta-analysis of randomized controlled trials.
Synthesis in BMC pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundPreterm delivery is the leading cause of neonatal morbidity and mortality. This study performed a systematic review and meta-analysis to compare the efficacy of transdermal nitroglycerin and oral nifedipine in managing preterm labor.
methodsA comprehensive search was conducted across multiple MEDLINE, Scopus, Web of Science, and the Cochrane Central Register of Controlled Trials for the randomized controlled trials comparing the effectiveness of nitroglycerin vs. nifedipine in the management of preterm labor. Primary outcomes were the prolongation of pregnancy and gestational age at delivery, while secondary outcomes included maternal side effects and neonatal outcomes. Statistical analyses were performed using RevMan 5.4 electronic databases, includingsoftware.
resultsEighteen studies were included. The meta-analysis revealed no significant difference between nitroglycerin and nifedipine in prolonging pregnancy for 48 h (RR = 0.93, 95% CI 0.81-1.07, p = 0.3), 7 days (RR = 0.99, 95% CI 0.88-1.11, p = 0.88), or beyond 7 days (RR = 0.92, 95% CI 0.76-1.1, p = 0.36). Both treatments showed no significant advantage in prolonging gestational age at delivery (MD = 0.25, 95% CI -0.61-1.12, p = 0.58). Nitroglycerin was associated with an increased risk of headache (RR = 2.23, 95% CI 1.23-4.05, p = 0.009), while nifedipine was linked to higher rates of tachycardia (RR = 0.51, 95% CI 0.38-0.69, p < 0.00001) and palpitations (R = 0.45, 95% CI 0.27-0.73, p = 0.001). No significant differences were observed in neonatal outcomes, including birth weight (MD = -44.28, 95% CI -266.80-178.24, p = 0.70) and NICU admission rates (RR = 0.99, 95% CI 0.61-1.59, p = 0.96).
conclusionsNitroglycerin and nifedipine demonstrate similar efficacy in prolonging pregnancy and influencing neonatal outcomes, though their side effect profiles differ. Nifedipine is associated with more tachycardia and palpitations, while nitroglycerin causes more headaches. Further high-quality studies are required due to current evidence's low to very low certainty.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.